Qualigen Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.47 Insider Own0.60% Shs Outstand36.68M Perf Week-8.22%
Market Cap11.15M Forward P/E- EPS next Y-0.61 Insider Trans35.40% Shs Float34.98M Perf Month-25.26%
Income-15.70M PEG- EPS next Q-0.13 Inst Own6.20% Short Float2.55% Perf Quarter-48.86%
Sales4.80M P/S2.32 EPS this Y45.60% Inst Trans-18.52% Short Ratio3.63 Perf Half Y-56.83%
Book/sh0.39 P/B0.75 EPS next Y-19.60% ROA-74.50% Target Price4.75 Perf Year-79.47%
Cash/sh0.25 P/C1.15 EPS next 5Y- ROE-113.40% 52W Range0.26 - 3.12 Perf YTD-72.76%
Dividend- P/FCF- EPS past 5Y65.40% ROI-136.60% 52W High-90.66% Beta-0.43
Dividend %- Quick Ratio2.20 Sales past 5Y- Gross Margin13.50% 52W Low12.12% ATR0.03
Employees39 Current Ratio2.40 Sales Q/Q27.30% Oper. Margin- RSI (14)18.99 Volatility16.28% 8.92%
OptionableYes Debt/Eq0.06 EPS Q/Q39.90% Profit Margin- Rel Volume0.00 Prev Close0.29
ShortableYes LT Debt/Eq0.00 EarningsAug 16 BMO Payout- Avg Volume245.53K Price0.29
Recom2.00 SMA20-14.70% SMA50-25.26% SMA200-53.90% Volume0 Change0.00%
Sep-14-22 05:02PM
Aug-25-22 06:45AM
Aug-18-22 09:15AM
Aug-16-22 07:30AM
Aug-01-22 08:30AM
Jul-06-22 09:00AM
Jun-14-22 09:00AM
Jun-07-22 09:04AM
Jun-06-22 06:10AM
Jun-02-22 09:00AM
May-26-22 09:15AM
May-20-22 09:15AM
May-13-22 06:00AM
May-10-22 09:17AM
May-03-22 02:24PM
Apr-29-22 09:15AM
Apr-18-22 06:25AM
Apr-12-22 10:15AM
Apr-05-22 09:15AM
Apr-01-22 08:00AM
Mar-30-22 09:15AM
Mar-22-22 09:15AM
Mar-15-22 09:15AM
Feb-22-22 09:15AM
Feb-15-22 09:15AM
Feb-01-22 09:15AM
Jan-18-22 09:15AM
Dec-14-21 09:18AM
Dec-01-21 03:25PM
Nov-29-21 03:50PM
Nov-22-21 10:23AM
Nov-15-21 09:00AM
Oct-19-21 09:00AM
Sep-15-21 07:30AM
Sep-08-21 07:30AM
Aug-31-21 06:22AM
Aug-23-21 09:58AM
Aug-17-21 10:01AM
Jul-14-21 07:30AM
Jul-07-21 10:37AM
Jun-08-21 07:30AM
Jun-02-21 07:30AM
May-19-21 07:30AM
May-18-21 02:10PM
May-14-21 01:35PM
Apr-26-21 07:00AM
Apr-19-21 01:16PM
Apr-06-21 09:30AM
Mar-18-21 08:30AM
Mar-09-21 08:30AM
Mar-08-21 08:30AM
Mar-01-21 08:30AM
Jan-26-21 09:00AM
Dec-30-20 11:16AM
Dec-22-20 09:00AM
Dec-18-20 03:07PM
Dec-16-20 10:25AM
Dec-15-20 09:00AM
Dec-08-20 09:00AM
Dec-02-20 09:00AM
Nov-30-20 09:40AM
Nov-13-20 09:00AM
Nov-05-20 09:00AM
Oct-28-20 09:00AM
Oct-08-20 09:00AM
Oct-01-20 09:00AM
Sep-21-20 11:53AM
Sep-17-20 09:00AM
Aug-31-20 09:00AM
Aug-28-20 08:00AM
Aug-20-20 08:00AM
Aug-14-20 05:24PM
Aug-06-20 03:59PM
Aug-04-20 04:05PM
Aug-02-20 05:32PM
Jul-30-20 08:00AM
Jul-22-20 08:00AM
Jul-13-20 08:00AM
Jul-10-20 04:05PM
Jul-08-20 05:19PM
Jul-07-20 08:00AM
Jul-01-20 08:00AM
Jun-10-20 08:00AM
Jun-04-20 08:00AM
Jun-02-20 08:00AM
May-26-20 07:00AM
Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Poirier Michael S.Chairman and CEOJun 22Buy0.5730,00017,100199,202Jun 22 04:55 PM
BROIDRICK AMY S.President/CSOJun 14Buy0.6230,00018,60034,500Jun 15 04:05 PM